• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Ribological GmbH

https://www.ribological.de
Link has been incorrect on 2015-01-02

Ribological, based in Mainz, Germany, is a subsidiary of BioNTech AG. Ribological develops pharmacologically optimised, RNA-based drugs for targeted immunotherapy for cancer. The Group parent, BioNTech, is a spin-off from Johannes Gutenberg University, Mainz. Together with its subsidiaries, the company researches and develops molecular diagnostics and targeted immunotherapies for personalised clinical application. *

 

	Start	2009-01-01 established
	End	2014-03-06 renamed
	Group	BioNTech (Group)
	Today	BioNTech RNA Pharmaceuticals GmbH
	Successor	BioNTech RNA Pharmaceuticals GmbH
	Industry	BIOTECH
	Industry 2	RNAi drug (RNAi therapeutic)
	Person	Kring, Michael Maximilian (High Tech Corporate Services GmbH 201402 Managing Director + interim CFO/CEO others)
	Person 2	Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)
	Region	Mainz
	Country	Germany
	Street	8 Hölderlinstr.
	City	55131 Mainz
	Tel	+49-6131-576270-0
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2011-12-25)
		* Document for �About Section�:
		Record changed: 2017-04-01

Advertisement

More documents for BioNTech (Group)

• [1] Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen....
• [2] BioNTech SE. (12/29/20). "Press Release: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of Comirnaty". New York, NY & Mainz....
• [3] BioNTech SE. (12/23/20). "Press Release: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine". New York, NY & Mainz....
• [4] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz....
• [5] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz....
• [6] BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz....
• [7] BioNTech SE. (12/16/20). "Press Release: BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine". Mainz & Shanghai....
• [8] BioNTech SE. (12/12/20). "Press Release: U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older". New York, NY & Mainz....
• [9] BioNTech SE. (12/11/20). "Press Release: Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19". New York, NY & Mainz....
• [10] BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.